Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2676
The RMR Group
RMR
$311M
| $2.79M | ﹤0.01% |
136,039
+1,865
| +1% | +$35.3K |
2015 Q4
42 quarters
|
|
2677
Eton Pharmaceutcials
ETON
$1.58B
| $2.79M | ﹤0.01% |
77,032
+8,237
| +12% | +$242K |
2022 Q2
16 quarters
|
|
2678
Vanguard Information Technology ETF
VGT
$156B
| $2.76M | ﹤0.01% |
23,113
-6,391
| -22% | -$700K |
2023 Q3
11 quarters
|
|
2679
Nutex Health
NUTX
$1.41B
| $2.74M | ﹤0.01% |
16,028
+965
| +6% | +$122K |
2025 Q2
4 quarters
|
|
2680
OrthoPediatrics
KIDS
$577M
| $2.74M | ﹤0.01% |
143,127
+4,030
| +3% | +$70.1K |
2018 Q2
32 quarters
|
|
2681
Ranpak Holdings
PACK
$310M
| $2.73M | ﹤0.01% |
373,622
+41,509
| +12% | +$239K |
2020 Q2
24 quarters
|
|
2682
Inhibrx
INBX
$1.33B
| $2.72M | ﹤0.01% |
28,678
+3,007
| +12% | +$301K |
2024 Q2
8 quarters
|
|
2683
Lightpath Technologies
LPTH
$618M
| $2.71M | ﹤0.01% |
165,900
+131,719
| +385% | +$1.84M |
2023 Q2
12 quarters
|
|
2684
Latham Group
SWIM
$707M
| $2.71M | ﹤0.01% |
419,078
+56,722
| +16% | +$319K |
2021 Q2
20 quarters
|
|
2685
Ooma
OOMA
$553M
| $2.7M | ﹤0.01% |
140,575
+66,729
| +90% | +$1.14M |
2017 Q2
36 quarters
|
|
2686
Wealthfront Corp
WLTH
$1.67B
| $2.7M | ﹤0.01% |
302,137
+4,536
| +2% | +$47.2K |
2026 Q1
1 quarter
|
|
2687
Backblaze
BLZE
$783M
| $2.69M | ﹤0.01% |
169,718
+48,450
| +40% | +$335K |
2023 Q4
10 quarters
|
|
2688
Donegal Group Class A
DGICA
$677M
| $2.69M | ﹤0.01% |
142,414
+2,894
| +2% | +$50.2K |
2013 Q2
52 quarters
|
|
2689
Waterstone Financial
WSBF
$354M
| $2.68M | ﹤0.01% |
129,105
+2,313
| +2% | +$43.1K |
2013 Q2
52 quarters
|
|
2690
Power Solutions International
PSIX
$1.16B
| $2.67M | ﹤0.01% |
68,591
-6,162
| -8% | -$339K |
2025 Q1
5 quarters
|
|
2691
DELISTED
Select Medical
SEM
| $2.66M | ﹤0.01% |
161,356
-1,543,247
| -91% | -$25.4M |
2013 Q2
52 quarters
|
|
2692
Krispy Kreme
DNUT
$526M
| $2.66M | ﹤0.01% |
754,599
+6,040
| +0.8% | +$21.6K |
2021 Q3
19 quarters
|
|
2693
Bobs Discount Furniture
BOBS
$1.86B
| $2.66M | ﹤0.01% |
168,237
+45,989
| +38% | +$571K |
2026 Q1
1 quarter
|
|
2694
Zevra Therapeutics
ZVRA
$672M
| $2.65M | ﹤0.01% |
184,818
+22,837
| +14% | +$254K |
2021 Q2
20 quarters
|
|
2695
Blend Labs
BLND
$234M
| $2.65M | ﹤0.01% |
1,548,935
-111,636
| -7% | -$178K |
2021 Q3
19 quarters
|
|
2696
Precision Drilling
PDS
$1.06B
| $2.64M | ﹤0.01% |
34,412
-3,292
| -9% | -$301K |
2024 Q2
8 quarters
|
|
2697
Perspective Therapeutics
CATX
$288M
| $2.64M | ﹤0.01% |
773,262
+111,944
| +17% | +$423K |
2023 Q1
13 quarters
|
|
2698
Yesway Inc
YSWY
$659M
| $2.63M | ﹤0.01% |
+129,777
| New | +$3.01M |
2026 Q2
0 quarters
|
|
2699
Digi Power X Inc
DGXX
$306M
| $2.62M | ﹤0.01% |
+481,453
| New | +$2.62M |
2026 Q2
0 quarters
|
|
2700
Akebia Therapeutics
AKBA
$219M
| $2.62M | ﹤0.01% |
2,300,438
+284,861
| +14% | +$339K |
2022 Q3
15 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.